Compare JMSB & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JMSB | SMTI |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.4M | 322.2M |
| IPO Year | 2022 | 2008 |
| Metric | JMSB | SMTI |
|---|---|---|
| Price | $23.11 | $32.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $27.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 227.5K | 95.7K |
| Earning Date | 10-28-2026 | 11-12-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ 24.17 | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | $16.55 | $13.07 |
| Revenue Next Year | $148.88 | $14.23 |
| P/E Ratio | $15.79 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $19.02 | $16.05 |
| 52 Week High | $24.26 | $35.52 |
| Indicator | JMSB | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 45.19 |
| Support Level | $22.60 | $30.40 |
| Resistance Level | $24.03 | $34.01 |
| Average True Range (ATR) | 0.51 | 1.00 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 37.70 | 75.84 |
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.